Financials
- Market Capitalization 701.35 M
- Employee 152
- Founded 2017
- CEO N/A
- Website www.allogene.com
- Headquarter California, United States
- FIGI BBG00KHRRDX3
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-1.57
Fiyat/satışlar oranı
—
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 2689 | CTMX CytomX Therapeutics, Inc. - Common Stock | 3.31 USD | -3.22% | -0.60% | +2.48% | +59.90% | 721.25 M USD | ||
| 2703 | BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 8.75 USD | -4.68% | -4.06% | +1.27% | -9.33% | 701.52 M USD | ||
| 2705 | TECX Tectonic Therapeutic, Inc. - Common Stock | 35.84 USD | -2.34% | -3.84% | +20.15% | +108.98% | 700.65 M USD | ||
| 2715 | ZVRA Zevra Therapeutics, Inc. - Common Stock | 11.64 USD | -1.77% | -2.18% | +19.75% | +9.40% | 691.23 M USD |